NFL BIOSCIENCES TO PRESENT AT THE H.C.WAINWRIGHT 1ST ANNUAL MENTAL HEALTH CONFERENCE
24 Juni 2022 - 6:00PM
NFL BIOSCIENCES TO PRESENT AT THE H.C.WAINWRIGHT 1ST ANNUAL MENTAL
HEALTH CONFERENCE
NFL BIOSCIENCES TO PRESENT AT THE H.C.WAINWRIGHT 1ST ANNUAL
MENTAL HEALTH CONFERENCE
NFL BIOSCIENCES (Euronext Growth Paris –
FR0014003XT0 – ALNFL), a biopharmaceutical company developing
botanical drugs for the treatment of addictions, is announcing
that Ignacio
Faus, Chief
Executive Officer of NFL
Biosciences, has been invited to
present in the
H.C. WAINWRIGHT
1st ANNUAL MENTAL HEALTH
CONFERENCE on June 27 and 28, 2022.
On this occasion, NFL Biosciences will have the
opportunity to present its activities and its development strategy
to US professional investors. In particular, Ignacio Faus will
detail the implementation of the Phase II/III clinical study of the
NFL-101 drug candidate for smoking cessation, which began in
January 2022 in France. He will also discuss the co-development
agreement for the NFL-301 drug candidate to reduce alcohol
consumption and the extension of intellectual property with the
approval of the second patent for NFL-101 in the United States,
China and South Korea.
About NFL Biosciences
NFL Biosciences is a biopharmaceutical company
based in the Montpellier area which develops botanical drug
candidates for the treatment of addictions. NFL Biosciences'
ambition is to bring new, natural, safer and more effective
therapeutic solutions to the entire world population, including
low- and middle-income countries. Its most advanced product, called
NFL-101, is a standardized, nicotine-free tobacco leaf extract
protected by two patent families. NFL Biosciences intends to offer
smokers who want to quit a natural, safe, easy-to-administer and
personalized alternative. NFL Biosciences is also developing
NFL-301, a natural drug candidate for the reduction of alcohol
consumption and has a drug development project for the treatment of
cannabis use disorders.
The shares of NFL Biosciences are listed on
Euronext Growth Paris (FR0014003XT0 – ALNFL). Find out more at
www.nflbiosciences.com
Contacts
Bruno Lafont – info@nflbiosciences.com - +33 4
11 93 76 67 Agence
Calyptus – nflbio@calyptus.net - +33 1 53 65 68 68
- 20220624_NFLBioscience_HCWrainwrightConference_EN
NFL Biosciences (EU:ALNFL)
Historical Stock Chart
Von Mär 2024 bis Apr 2024
NFL Biosciences (EU:ALNFL)
Historical Stock Chart
Von Apr 2023 bis Apr 2024
